the median age at diagnosis is 66 years. Although many older patients will die from competing causes, particularly those with frailty, 70% of deaths due to prostate cancer occur in men older than 75 years. Regarding
In 1995 the crude incidence of prostate cancer in France was estimated to be 260–300 out of 100 000 for men aged between 60 and 70 years and over 500 out of 100 000 for men over 70 years of age. The majority of men (73%) are diagnosed when they are over 70 years old. The...
Men over 50 are more likely to develop prostate cancer, and the risk increases with age. Between 70 and 74 is the most common age at which men are diagnosed. However, the number of men aged 40 to 59 diagnosed with prostate cancer has increased six-fold in recent years. At present, the...
This corresponded to 12 per cent of all male cancer deaths (excluding ICD-10 code C44), making it the second most common cause of cancer-specific death. The age-standardised mortality rate based on the old European standard population was 19 deaths per 100,000 person-years in Germany. Due...
Burgeoning research on advanced PC and castration-resistant prostate cancer in recent years have paved the way for a new era of integrated treatment methods including novel endocrine drugs, chemotherapy, targeted therapy, and immunotherapy. Future therapies involve precision treatment guided by genetic ...
My Dad is suffering prostate cancer Stage 4. It had spread to bone, liver and some other area. He is 77.5 years old. He had received: Hormone therapy Chemotherapy Lutetium LU 177 But his cancer is still spreading. My Dad is a bit weak now, he lost his appetite and is also anaemic....
Prostate cancer is the second most common malignancy in men worldwide and consists of a mixture of tumor and non-tumor cell types. To characterize the prostate cancer tumor microenvironment, we perform single-cell RNA-sequencing on prostate biopsies, prostatectomy specimens, and patient-derived organo...
Re: Prostate Cancer in the Elderly: Frequency of Advanced Disease at Presentation and Disease-Specific Mortality - The Journal of Urologyprostateprostatic neoplasmsprostatectomyroboticsphysician's practice patternsJ Urol. 2012 Jun;187(6):2096-7. doi: 10.1016/j.juro.2012.03.039. Epub 2012 Apr 12....
Prostate cancer (PC) is one of the most common cancers in males and the fifth leading reason of death. Age, ethnicity, family history, and genetic defects are major factors that determine the aggressiveness and lethality of PC. The African population is
Most patients with prostate cancer inevitably progress to castration-resistant prostate cancer (CRPC), at which stage chemotherapeutics like docetaxel become the first-line treatment. However, chemotherapy resistance typically develops after an initial p